AM-2201

AM-2201
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule II; DE: Anlage II (Authorized trade only, not prescriptible); NZ: Temporary Class; UK: Class B; US: Schedule I; UN: Psychotropic Schedule II;
Identifiers
	IUPAC name 1-[(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone;
CAS Number	335161-24-5 ;
PubChem CID	53393997;
ChemSpider	24751884 ;
UNII	TBJ0966F1O;
KEGG	C22771;
CompTox Dashboard (EPA)	DTXSID50187158 ;
Chemical and physical data
Formula	C24H22FNO
Molar mass	359.444 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(C1=CN(CCCCCF)C2=C1C=CC=C2)C3=CC=CC4=C3C=CC=C4;
	InChI InChI=1S/C24H22FNO/c25-15-6-1-7-16-26-17-22(20-12-4-5-14-23(20)26)24(27)21-13-8-10-18-9-2-3-11-19(18)21/h2-5,8-14,17H,1,6-7,15-16H2 ; Key:ALQFAGFPQCBPED-UHFFFAOYSA-N ;
	(what is this?) (verify)

AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.